NO854460L - Syntetisk hepatitis-b-vaksine inbefattende baade t-celle og b-celledeterminanter. - Google Patents
Syntetisk hepatitis-b-vaksine inbefattende baade t-celle og b-celledeterminanter.Info
- Publication number
- NO854460L NO854460L NO854460A NO854460A NO854460L NO 854460 L NO854460 L NO 854460L NO 854460 A NO854460 A NO 854460A NO 854460 A NO854460 A NO 854460A NO 854460 L NO854460 L NO 854460L
- Authority
- NO
- Norway
- Prior art keywords
- cells
- hepatitis
- cell
- amino acid
- vaccine including
- Prior art date
Links
- 210000001744 T-lymphocyte Anatomy 0.000 title abstract 2
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 title 1
- 241000700721 Hepatitis B virus Species 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 101710118982 Pathogen-related protein Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 210000001541 thymus gland Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Selective Calling Equipment (AREA)
- Air Bags (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/587,983 US4599231A (en) | 1984-03-09 | 1984-03-09 | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US06/588,122 US4599230A (en) | 1984-03-09 | 1984-03-09 | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| PCT/US1985/000360 WO1985004103A1 (en) | 1984-03-09 | 1985-03-06 | Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO854460L true NO854460L (no) | 1986-01-08 |
| NO167359B NO167359B (no) | 1991-07-22 |
| NO167359C NO167359C (no) | 1991-10-30 |
Family
ID=27080174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO85854460A NO167359C (no) | 1984-03-09 | 1985-11-08 | Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0155146B1 (no) |
| AT (1) | ATE82135T1 (no) |
| AU (2) | AU579148B2 (no) |
| CA (1) | CA1253069A (no) |
| DE (1) | DE3586801D1 (no) |
| DK (1) | DK516385A (no) |
| FI (1) | FI84558C (no) |
| IL (3) | IL90035A (no) |
| NO (1) | NO167359C (no) |
| NZ (2) | NZ211356A (no) |
| WO (1) | WO1985004103A1 (no) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2560890B1 (fr) * | 1984-03-07 | 1987-10-16 | Grp Genie Genetique | Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention |
| AU617292B2 (en) * | 1986-06-20 | 1991-11-28 | Scripps Clinic And Research Foundation | T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen |
| US6054438A (en) * | 1987-01-07 | 2000-04-25 | Imperial Cancer Research Technology Limited | Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin |
| AU1668788A (en) * | 1987-05-26 | 1988-12-01 | Wistar Institute, The | Method of vaccination for hepatitis b virus |
| DE10299017I2 (de) * | 1987-06-22 | 2005-05-25 | Medeva Holdings Bv | Hepatitis-B-Oberfl{chenantigen enthaltendes Peptid. |
| JPH03500408A (ja) * | 1987-09-04 | 1991-01-31 | ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ | 増強された安定性を有するペプチド複合体 |
| EP0491077A1 (en) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | A composition used as a therapeutic agent against chronic viral hepatic diseases |
| GB9325772D0 (en) * | 1993-12-16 | 1994-02-16 | Smithkline Beecham Biolog | Novel compounds |
| WO1997039029A2 (en) * | 1996-04-18 | 1997-10-23 | Abbott Laboratories | An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof |
| JP2001500738A (ja) | 1996-09-17 | 2001-01-23 | カイロン コーポレイション | 細胞内疾患を処置するための組成物および方法 |
| AU736032B2 (en) * | 1996-12-30 | 2001-07-26 | Innogenetics N.V. | Annexin V-binding polypeptides derived from HBsAg and their uses |
| US6881723B1 (en) | 1998-11-05 | 2005-04-19 | Powderject Vaccines, Inc. | Nucleic acid constructs |
| ES2330904B1 (es) | 2005-09-21 | 2010-09-23 | Fundacio Centre De Recerca En Sanitat Animal | Polinucleotidos de haemophilus parasuis y su uso. |
| PT2476435T (pt) | 2006-08-11 | 2018-03-05 | Life Sciences Res Partners Vzw | Péptidos imunogénicos e a sua utilização em distúrbios imunitários |
| EP2244733B1 (en) | 2008-02-14 | 2015-06-17 | Life Sciences Research Partners VZW | Immunotherapy targeting intracellular pathogens |
| EP2247306B1 (en) | 2008-02-14 | 2018-04-18 | Life Sciences Research Partners VZW | Immunogenic control of tumours and tumour cells |
| PL2643345T3 (pl) | 2010-11-25 | 2021-08-16 | Imnate Sarl | Immunogenne peptydy do zastosowania w zapobieganiu i/lub leczeniu chorób zakaźnych, chorób autoimmunologicznych, odpowiedzi immunologicznych na czynniki allogeniczne, chorób alergicznych, nowotworów, odrzuceniu przeszczepów oraz odpowiedzi immunologicznych skierowanych przeciwko wektorom wirusowym stosowanym w terapii genowej lub szczepieniu genowym |
| GB201201511D0 (en) | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
| ES2834072T3 (es) | 2012-06-11 | 2021-06-16 | Univ Xiamen | Polipéptidos y anticuerpos para el tratamiento de la infección por vhb y enfermedades relacionadas |
| GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
| US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
| CA2995771A1 (en) | 2015-09-25 | 2017-03-30 | Imcyse Sa | Improved methods and compounds for eliminating immune responses to therapeutic agents |
| BR112018071466A2 (pt) | 2016-04-19 | 2019-03-19 | Imcyse Sa | novos peptídeos de ligação a cd1d imunogênicos |
| EP3617317A4 (en) | 2017-02-17 | 2021-01-13 | Xiamen University | PEPTIDIC SUPPORT FOR THE DISPLAY OF A TARGET POLYPEPTIDE AND ASSOCIATED USE |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA792485B (en) * | 1978-06-07 | 1980-06-25 | New York Blood Center Inc | Vaccine for active immunization containing hepatitis b surface and/or e-antigens |
| FR2480779B2 (fr) * | 1979-08-30 | 1986-07-18 | Anvar | Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur |
| ES8105035A1 (es) * | 1978-12-22 | 1981-05-16 | Biogen Nv | Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv |
| US4415491A (en) * | 1980-01-14 | 1983-11-15 | The Regents Of The University Of California | Synthetic vaccine peptide epitomes of hepatitis B surface antigen |
| IL63224A (en) * | 1980-07-17 | 1985-05-31 | Scripps Clinic Res | Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom |
| IL61904A (en) * | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
| DE3275998D1 (en) * | 1981-12-22 | 1987-05-14 | Baylor College Medicine | Immunological composition and method for hepatitis b virus |
| US4483793A (en) * | 1982-10-04 | 1984-11-20 | The Regents Of The University Of California | Dimeric oligopeptides as heptenic epitopic sites for hepatitis |
| JPS5974985A (ja) * | 1982-10-19 | 1984-04-27 | Takeda Chem Ind Ltd | 新規ｄｎａ |
| NZ207394A (en) * | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
-
1985
- 1985-03-06 WO PCT/US1985/000360 patent/WO1985004103A1/en active IP Right Grant
- 1985-03-06 AU AU41159/85A patent/AU579148B2/en not_active Ceased
- 1985-03-07 NZ NZ211356A patent/NZ211356A/xx unknown
- 1985-03-07 AT AT85301588T patent/ATE82135T1/de not_active IP Right Cessation
- 1985-03-07 DE DE8585301588T patent/DE3586801D1/de not_active Expired - Lifetime
- 1985-03-07 NZ NZ227731A patent/NZ227731A/xx unknown
- 1985-03-07 EP EP85301588A patent/EP0155146B1/en not_active Expired - Lifetime
- 1985-03-08 IL IL90035A patent/IL90035A/xx not_active IP Right Cessation
- 1985-03-08 CA CA000476041A patent/CA1253069A/en not_active Expired
- 1985-03-08 IL IL74545A patent/IL74545A/xx unknown
- 1985-11-07 FI FI854396A patent/FI84558C/fi not_active IP Right Cessation
- 1985-11-08 DK DK516385A patent/DK516385A/da not_active Application Discontinuation
- 1985-11-08 NO NO85854460A patent/NO167359C/no unknown
-
1988
- 1988-12-13 AU AU26823/88A patent/AU623106B2/en not_active Ceased
-
1989
- 1989-04-19 IL IL90035A patent/IL90035A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ227731A (en) | 1990-07-26 |
| DE3586801D1 (de) | 1992-12-17 |
| WO1985004103A1 (en) | 1985-09-26 |
| EP0155146A2 (en) | 1985-09-18 |
| AU623106B2 (en) | 1992-05-07 |
| FI854396A (fi) | 1985-11-07 |
| FI854396A0 (fi) | 1985-11-07 |
| AU4115985A (en) | 1985-10-11 |
| EP0155146B1 (en) | 1992-11-11 |
| DK516385D0 (da) | 1985-11-08 |
| FI84558C (fi) | 1991-12-27 |
| IL90035A0 (en) | 1989-12-15 |
| DK516385A (da) | 1985-11-08 |
| IL74545A (en) | 1990-11-05 |
| IL74545A0 (en) | 1985-06-30 |
| ATE82135T1 (de) | 1992-11-15 |
| EP0155146A3 (en) | 1988-01-20 |
| AU2682388A (en) | 1989-05-25 |
| FI84558B (fi) | 1991-09-13 |
| CA1253069A (en) | 1989-04-25 |
| NZ211356A (en) | 1990-07-26 |
| NO167359B (no) | 1991-07-22 |
| AU579148B2 (en) | 1988-11-17 |
| IL90035A (en) | 1990-11-05 |
| NO167359C (no) | 1991-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO854460L (no) | Syntetisk hepatitis-b-vaksine inbefattende baade t-celle og b-celledeterminanter. | |
| LU91498I2 (fr) | Etanercept et ses dérivés pharmaceutiquement acceptables. | |
| AU8223187A (en) | T cell epitopes of the hepatitis b virus nucleocapsid protein | |
| EP0217919A4 (en) | TYPE-SPECIFIC PAPILLOMAVIRUS DNA SEQUENCES AND PEPTIDES. | |
| ES2097878T3 (es) | Fijacion de p53 sobre el adn mediante una secuencia especifica. | |
| DE69030124T2 (de) | Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus | |
| DK235289D0 (da) | Ekspression af hapatitis b s- og praes2-proteiner i methylotrophe gaerarter | |
| EP0485347A3 (en) | Recombinant hepatitis delta antigen, process for the purification and use thereof | |
| EP0248642A3 (en) | Interleukin-2 induced antineoplastic peptide | |
| SU1380209A1 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ | |
| ES8801959A1 (es) | Un procedimiento para ensayos de sangre humana respecto de la presencia de anticuerpos frente al agente etiologico viral de sida | |
| PT89041A (pt) | Metodo de preparacao de diagnosticos e vacinas nanbv |